MARKET

PTCHF

PTCHF

Puretech Health
OTCPK
1.650
NaN%
Opening 09:30 05/21 EDT
OPEN
--
PREV CLOSE
1.650
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.900
52 WEEK LOW
1.520
MARKET CAP
396.31M
P/E (TTM)
8.38
1D
5D
1M
3M
1Y
5Y
1D
PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial
Barchart · 1d ago
Weekly Report: what happened at PTCHF last week (0512-0516)?
Weekly Report · 2d ago
Weekly Report: what happened at PTCHF last week (0505-0509)?
Weekly Report · 05/12 11:29
Weekly Report: what happened at PTCHF last week (0428-0502)?
Weekly Report · 05/05 11:31
Weekly Report: what happened at PTCHF last week (0421-0425)?
Weekly Report · 04/28 11:42
PureTech Health: Notice of Results
Barchart · 04/23 01:00
Weekly Report: what happened at PTCHF last week (0414-0418)?
Weekly Report · 04/21 11:41
Weekly Report: what happened at PTCHF last week (0407-0411)?
Weekly Report · 04/14 11:29
More
About PTCHF
PureTech Health plc is a clinical stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company's R&D engine has resulted in the development of around 29 therapeutics and therapeutic candidates, including two that have received both United States Food and Drug Administration (FDA) clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. Its product candidates include LYT-100, LYT-200, SPT-300, SPT-310 and SPT-320. LYT-100 (deupirfenidone) is being developed internally by the Company for the treatment of idiopathic pulmonary fibrosis (IPF). LYT-200 is being developed for the treatment of hematological malignancies, such as acute myeloid leukemia and high-risk myelodysplastic syndromes, as well as locally advanced/metastatic solid tumors. SPT-300 is an oral prodrug of allopregnanolone, which is being advanced for the treatment of anxious depression.

Webull offers Puretech Health PLC stock information, including OTCPK: PTCHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTCHF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTCHF stock methods without spending real money on the virtual paper trading platform.